Kevin Pojasek

Kevin joined Enara Bio in 2018 bringing 15 years of leadership and strategic investment experience in the biotech and pharmaceutical sector. He is also a Venture Partner at SV Health Investors and was previously an Entrepreneur-in-Residence at Atlas Ventures.

Kevin was formerly Chief Strategy and Business Officer and a member of the executive leadership team at Immunocore. In this role, he was responsible for shaping the company’s corporate, R&D and growth strategies, as well as for overseeing business development. He was also co-head of the company’s Infectious Disease Unit and helped lead the Bill & Melinda Gates Foundation investment of up to $40 million. Prior to joining Immunocore, Kevin was President and CEO of Quartet Medicine, a company he co-founded in 2013 while at Atlas Ventures and held senior executive R&D and corporate development roles at several other venture-backed companies.

Kevin has a PhD from the Biological Engineering Department at Massachusetts Institute of Technology.